Here’s why the Tilray Brands stock may surge soon despite major risks
Setup: falling wedge + small inverted H&S with price below key support ($7) and far under 50/100-day EMAs; earnings show record revenue ($206.7M), double-digit growth, improving margins (wellness …
TSX Penny Stocks: 3 Picks With Market Caps Over CA$6M
Despite recent inflationary pressures and concerns about consumer confidence, the Canadian S&P/TSX index has shown resilience, climbing 7.5% from its mid-March low. In such a fluctuating market, penny …
Tilray Posted Record Numbers Last Quarter, but Where the Bulk of Its Growth Has Come From Over the Past 4 Years Might Surprise You
Tilray Brands (NASDAQ: TLRY) is a leading cannabis company based in Canada. However, despite leading the industry, intense competition in the domestic market has made it exceeding …
245% Upside Potential for Sundial Growers (SNDL) After 18% YTD Slide
SNDL Inc. (NASDAQ:SNDL) currently trades at $1.36, while the average analyst price target sits at $4.70, implying an upside of roughly 245% from current levels. SNDL is Canada’s largest private-sector …
NLCP And MSOS: Cannabis REIT Vs. ETF
NLCP’s 12% dividend yield, low debt, and resilient rent collections add downside defense amid cannabis oversupply risks. See more here.
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
NLCP And MSOS: Cannabis REIT Vs. ETF
NLCP’s 12% dividend yield, low debt, and resilient rent collections add downside defense amid cannabis oversupply risks. See more here.
Why The Story Around Trulieve Cannabis (CNSX:TRUL) Is Shifting With New Valuation Assumptions
Trulieve Cannabis is back in focus after an updated fair value estimate edges from CA$19.53 to CA$20.36, a measured reset rather than a sweeping overhaul. That shift lines up with broader Street …
Assessing Trulieve Cannabis (CNSX:TRUL) Valuation After New Dabstract Partnership And Recent Share Price Moves
Why the Dabstract partnership matters for Trulieve Cannabis The latest move driving attention to Trulieve Cannabis (CNSX:TRUL) is its new partnership with concentrate brand Dabstract to bring High …
NewLake Capital Partners: Collect A Double-Digit Yield From This Cannabis Landlord
NewLake Capital Partners (NLCP) offers a near-12% yield with strong occupancy, low debt and rising dividends—an overlooked cannabis REIT.
Cannabis stocks on track for best week of 2026 as FDA loosens CBD enforcement
Tilray Brands, Canopy Growth, and Curaleaf Holdings stocks are surging after the FDA says it won’t enforce some regulations for CBD products.
Tilray Brands’ strong cannabis sales and upbeat outlook keeps Jefferies analysts bullish
Tilray Inc (NASDAQ:TLRY) earned a repeat ‘Buy’ rating from Jefferies analysts after what it described as a solid third quarter earnings report, pointing to improving fundamentals and increased …
Cambria Cannabis ETF Closes Up Shop as Investor Interest Fades
A cannabis ETF has come down from its high. Cambria Investment Management recently announced its Cambria Cannabis ETF (TOKE) is closing up shop. Shareholders have until April 17 to sell their holdings …
Oppenheimer Lowers Chicago Atlantic Real Estate Finance, Inc. (REFI) from Outperform to Perform
Chicago Atlantic Real Estate Finance, Inc. (NASDAQ:REFI) is one of the 11 Best Marijuana Stocks to Buy Right Now. On March 16, 2026, Oppenheimer lowered Chicago Atlantic Real Estate Finance, Inc.
Thinking about buying Canopy Growth stock? You may want to wait for this to happen first
The main reason for investing in Canopy Growth over the years has been due to the hope that the U.S. might legalize marijuana.
Recent Comments